1
|
Clark BJ, LaChance PA, Winter SS, Mehlman ML, Butler W, LaCour A, Taube JS. Comparison of head direction cell firing characteristics across thalamo-parahippocampal circuitry. Hippocampus 2024; 34:168-196. [PMID: 38178693 PMCID: PMC10950528 DOI: 10.1002/hipo.23596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2023] [Revised: 11/24/2023] [Accepted: 12/03/2023] [Indexed: 01/06/2024]
Abstract
Head direction (HD) cells, which fire persistently when an animal's head is pointed in a particular direction, are widely thought to underlie an animal's sense of spatial orientation and have been identified in several limbic brain regions. Robust HD cell firing is observed throughout the thalamo-parahippocampal system, although recent studies report that parahippocampal HD cells exhibit distinct firing properties, including conjunctive aspects with other spatial parameters, which suggest they play a specialized role in spatial processing. Few studies, however, have quantified these apparent differences. Here, we performed a comparative assessment of HD cell firing characteristics across the anterior dorsal thalamus (ADN), postsubiculum (PoS), parasubiculum (PaS), medial entorhinal (MEC), and postrhinal (POR) cortices. We report that HD cells with a high degree of directional specificity were observed in all five brain regions, but ADN HD cells display greater sharpness and stability in their preferred directions, and greater anticipation of future headings compared to parahippocampal regions. Additional analysis indicated that POR HD cells were more coarsely modulated by other spatial parameters compared to PoS, PaS, and MEC. Finally, our analyses indicated that the sharpness of HD tuning decreased as a function of laminar position and conjunctive coding within the PoS, PaS, and MEC, with cells in the superficial layers along with conjunctive firing properties showing less robust directional tuning. The results are discussed in relation to theories of functional organization of HD cell tuning in thalamo-parahippocampal circuitry.
Collapse
Affiliation(s)
- Benjamin J Clark
- Department of Psychology, University of New Mexico, Albuquerque, New Mexico, USA
| | - Patrick A LaChance
- Department of Psychological and Brain Sciences, Center for Cognitive Neuroscience, Dartmouth College, Hanover, New Hampshire, USA
| | - Shawn S Winter
- Department of Psychological and Brain Sciences, Center for Cognitive Neuroscience, Dartmouth College, Hanover, New Hampshire, USA
| | - Max L Mehlman
- Department of Psychological and Brain Sciences, Center for Cognitive Neuroscience, Dartmouth College, Hanover, New Hampshire, USA
| | - Will Butler
- Department of Psychological and Brain Sciences, Center for Cognitive Neuroscience, Dartmouth College, Hanover, New Hampshire, USA
| | - Ariyana LaCour
- Department of Psychology, University of New Mexico, Albuquerque, New Mexico, USA
| | - Jeffrey S Taube
- Department of Psychological and Brain Sciences, Center for Cognitive Neuroscience, Dartmouth College, Hanover, New Hampshire, USA
| |
Collapse
|
2
|
Bharathidasan K, Oti-Nimoh J, Pawar D, Butler W, Horn R, Nugent K. Refractory thrombotic thrombocytopenia purpura following a near-drowning experience in a 19-year-old patient. Am J Med Sci 2023. [DOI: 10.1016/s0002-9629(23)00215-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
|
3
|
Butler W. TU-D-201-02: Physicist's Responsibility On “End-Of-Life for Brachytherapy Devices and Software. Med Phys 2015. [DOI: 10.1118/1.4925655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
4
|
Butler W, Merrick G, Kurko B, Bittner N. SU-E-J-230: Effect of Metal Hip Prosthesis On the Accuracy of Electromagnetic Localization and Tracking. Med Phys 2014. [DOI: 10.1118/1.4888283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
5
|
Younis A, Hawkins K, Dizer S, Hughes A, Butler W, Garelnabi M. Ovarian stimulation for IUI-IVF alter cytokine, chemokine, and antioxidant levels in women with endometriosis, PCOS, or unexplained infertility. Fertil Steril 2013. [DOI: 10.1016/j.fertnstert.2013.07.579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
6
|
Butler W, Merrick G. SU-E-T-296: A Few Dosimetric Quality Indicators Provide Enough Dose Volume Histogram Information to Calculate Accurate Radiobiological Parameters in a Randomized Prostate Brachytherapy Trial. Med Phys 2013. [DOI: 10.1118/1.4814730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
7
|
Kurko B, Butler W, Merrick G. SU-E-J-154: Effect of Metal Hip Prostheses On the Accuracy of Electromagnetic Localization and Tracking. Med Phys 2013. [DOI: 10.1118/1.4814366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
8
|
Younis A, Clower C, Nelsen D, Butler W, Garelnabi M. The relationship between pregnancy and oxidative stress markers on patients undergoing IVF/IUI. Fertil Steril 2011. [DOI: 10.1016/j.fertnstert.2011.07.927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
9
|
|
10
|
Butler W, Merrick G, Allen Z, White B. SU-GG-T-90: Comparison of Annulus and Sector Dosimetry between Prostate Brachytherapy Biochemical Failures and Matched Non-Failures. Med Phys 2010. [DOI: 10.1118/1.3468478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
11
|
Butler W, Merrick G, Reed J, Kurko B, Murray B. SU-GG-J-91: Electromagnetic Transponders Indicate Prostate Size Increase Followed by Decrease during and after a Course of External Beam Radiation Therapy. Med Phys 2010. [DOI: 10.1118/1.3468315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
12
|
|
13
|
Turner JS, Chen CS, Butler W, Bearden J, Garrett-Mayer E, Onicescu G, Kraft AS. Bortezomib therapy for prostate specific antigen (PSA)-only relapse after definitive local therapy. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e16053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e16053 Background: We conducted a single arm, phase II trial of single-agent bortezomib, a proteasome inhibitor, in patients with prostate cancer with biochemical recurrence (PSA relapse) after definitive local therapy. Eligible patients had previous radical prostatectomy and/or radiation therapy (including brachytherapy), and a rising PSA over 1 ng/mL without bone scan evidence of metastasis. The primary goal of this study was to determine the PSA response to single agent bortezomib. Secondary goal was to identify the time to PSA relapse after bortezomib therapy defined as time from nadir to PSA >1ng/ml. Methods: Treatment was composed of bortezomib 1.3mg/m2 IV on days 1,4,8,11 then 10 days off for the first two cycles. The third cycle was comprised of weekly bortezomib therapy for three out of four weeks. Sixteen patients were enrolled and treated at 4 sites with13 evaluable patients. Results: Median baseline PSA was 12.0 ng/ml. 3 of 13 patients (23%) achieved complete responses and 1 a partial response (PR) for a response rate of 30% (95% CI: 0.09 –0.61). Median time to PSA relapse in these 3 patients was 6.0 months. Linear longitudinal modeling was used to compare the rate of increase in PSA prior to treatment versus during treatment with bortezomib and found that treatment significantly decreased the slope of log PSA during treatment, slowing PSA rise (p = 0.003). The major toxicity associated with bortezomib therapy was peripheral neuropathy (7 pts, grade 3 in 3 pts) requiring dose reductions in 3 cases and discontinuation of therapy in 4 patients. Other toxicities included non-neutropenic infections (shingles in 2 pts), 1 small bowel ileus (grade 3), and 1 case of thrombocytopenia (grade 3). Conclusions: In a small number of patients there was a 30% PSA response rate to single agent bortezomib therapy. Further investigations using bortezomib as a single-agent or in combination are warranted in this patient population. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- J. S. Turner
- Medical University of South Carolina, Charleston, SC; Loma Linda University, Loma Linda, CA; South Carolina Oncology Associates, P.A., Columbia, SC; Spartanburg Regional Healthcare System, Spartanburg, SC
| | - C. S. Chen
- Medical University of South Carolina, Charleston, SC; Loma Linda University, Loma Linda, CA; South Carolina Oncology Associates, P.A., Columbia, SC; Spartanburg Regional Healthcare System, Spartanburg, SC
| | - W. Butler
- Medical University of South Carolina, Charleston, SC; Loma Linda University, Loma Linda, CA; South Carolina Oncology Associates, P.A., Columbia, SC; Spartanburg Regional Healthcare System, Spartanburg, SC
| | - J. Bearden
- Medical University of South Carolina, Charleston, SC; Loma Linda University, Loma Linda, CA; South Carolina Oncology Associates, P.A., Columbia, SC; Spartanburg Regional Healthcare System, Spartanburg, SC
| | - E. Garrett-Mayer
- Medical University of South Carolina, Charleston, SC; Loma Linda University, Loma Linda, CA; South Carolina Oncology Associates, P.A., Columbia, SC; Spartanburg Regional Healthcare System, Spartanburg, SC
| | - G. Onicescu
- Medical University of South Carolina, Charleston, SC; Loma Linda University, Loma Linda, CA; South Carolina Oncology Associates, P.A., Columbia, SC; Spartanburg Regional Healthcare System, Spartanburg, SC
| | - A. S. Kraft
- Medical University of South Carolina, Charleston, SC; Loma Linda University, Loma Linda, CA; South Carolina Oncology Associates, P.A., Columbia, SC; Spartanburg Regional Healthcare System, Spartanburg, SC
| |
Collapse
|
14
|
Younis A, Carnovale D, Eroglu A, Butler W. Enhanced survival of human failed to fertilize oocytes cryopreserved using intra- and extracellular sugars and dimethylsulfoxide. Fertil Steril 2008. [DOI: 10.1016/j.fertnstert.2008.07.1163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
15
|
Butler W, Stewart R, Merrick G. SU-GG-T-42: Neither Dosimetric Nor Radiobiological Parameters Predict For Biochemical Control in a Large Permanent Prostate Brachytherapy Population. Med Phys 2008. [DOI: 10.1118/1.2961792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
16
|
Butler W, Stewart R, Merrick G. SU-GG-T-410: Detailed Radiobiological Analysis Does Not Distinguish Between Biochemical Failures in a Case Control Study of Permanent Prostate Brachytherapy Patients. Med Phys 2008. [DOI: 10.1118/1.2962158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
17
|
Mata LJ, Kronmal RA, García B, Butler W, Urrutia JJ, Murillo S. Breast-feeding, weaning and the diarrhoeal syndrome in a Guatemalan Indian village. Ciba Found Symp 2008:311-38. [PMID: 1049556 DOI: 10.1002/9780470720240.ch17] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Prospective studies in Mayan Indian children living in their natural setting were carried out from 1964 through 1974; observations began at birth and extended at least throughout the first three years of life. Adequate growth and survival were characteristic of exclusively breast-fed infants in the first months of life. Despite the high rate of infection, children exhibited a considerable resistance to intestinal protozoa, enterobacteriaceae and enteric viruses. Resistance against colonic invaders is attributed to the bifidus flora, and that against agents acting in the small bowel, to specific antibodies present in colostrum and milk. Diarrhoeal disease was least in this period and increased with weaning to reach maximum peaks at the time of weaning. The protracted weaning consisted of progressive administration of foods of low biological value given under deficient sanitary conditions. The nutrient value of the diet as a function of the child's weight was adequate in protein but in most cases it was markedly deficient in calories. Infectious diseases, particularly diarrhoea, were found associated with pronounced reductions in the already deficient calorie intake. Infection and infectious disease were common particularly during the first 6 to 18 months of life. Weight loss was a frequent finding during and after episodes of disease. The consequence of the malnutrition-infection interaction is a marked stunting of growth, clearly evident from examination of the growth curves of village children. Nutrient intake did not correlate with growth velocity. By contrast, the duration of breast-feeding was strongly associated with growth in the linear segment of the curve, while in the period of faster growth the correlation was inverse. On the other hand, morbidity was inversely correlated with calorie and protein intake and this was more obvious in the second than in the first year of life. The data indicate that infection is one of the leading factors associated with reduced calorie (and protein) intakes during the critical period of onset of malnutrition and mortality in childhood. By preventing infection, particularly diarrhoea, the food intake, nutrition and growth of children could be significantly improved.
Collapse
|
18
|
Brammer S, Merrick G, Butler W, Wallner K, Anderson R, Adamovich E, Allen Z, Galbreath R, Lief J. The Impact of Needle Trauma on Urinary, Bowel and Erectile Function Following Transperineal Template Guided Prostate Saturation Biopsy: Implications for Brachytherapy. Int J Radiat Oncol Biol Phys 2007. [DOI: 10.1016/j.ijrobp.2007.07.1437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
19
|
Merrick G, Galbreath R, Butler W, Wallner K, Allen Z, Brammer S, Moyad M. Patterns of Death Following Permanent Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 2007. [DOI: 10.1016/j.ijrobp.2007.07.322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
20
|
Niehaus A, Merrick G, Bittner N, Butler W, Wallner K, Allen Z, Galbreath R, Lief J. The Role of Trospium Chloride in Brachytherapy-Related Detrusor Overactivity. Int J Radiat Oncol Biol Phys 2007. [DOI: 10.1016/j.ijrobp.2007.07.1477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
21
|
Bittner N, Merrick G, Wallner K, Lief J, Butler W, Allen Z, Galbreath R. The Impact of Urinary Storm on Late Urinary Function Following Permanent Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 2007. [DOI: 10.1016/j.ijrobp.2007.07.1969] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
22
|
Grimm P, Merrick G, Blasko J, Sylvester J, Allen Z, Butler W, Chaudry U, Sitter M. The Effect of the Time Interval Between Brachytherapy and Post-implant Dosimetric Evaluation on Dosimetric Quality: Analysis of the Pro-qura Database. Int J Radiat Oncol Biol Phys 2007. [DOI: 10.1016/j.ijrobp.2007.07.1402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
23
|
Galbreath R, Merrick GS, Butler W, Wallner K, Allen Z, Adamovich E. Effect of obesity on overall survival following permanent prostate brachytherapy. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.15576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
15576 Background: To evaluate the impact of obesity on cause-specific (CSS), biochemical progression-free (bPFS) and overall survival (OS) following prostate brachytherapy. Methods: From April 1995 through March 2003, 1,093 consecutive patients underwent brachytherapy for clinical T1b-T3a (2002 AJCC) prostate cancer. The median follow up was 5.6 years. All patients were implanted at least 3 years prior to analysis. Evaluated body mass index (BMI) subgroups were < 25 (n=258), 25.0 to 29.9 (n=547), 30.0 to 34.9 (n=214) and = 35 (n=74) kg/m2, respectively. Four-hundred and thirty (39.9%) and 589 (53.9%) of the patients received androgen deprivation therapy or supplemental external beam radiation therapy, respectively. Multiple clinical, treatment and dosimetric parameters were evaluated as predictors of CSS, bPFS and OS. Results: The 11 year CSS, bPFS and OS for the entire cohort were 97.5%, 95.6% and 77.6% respectively. BMI did not impact CSS or bPFS for any of the BMI cohorts. However, OS was statistically lower in patients with a BMI < 25 kg/m2 (p = 0.014). A Cox linear regression analysis demonstrated that Gleason score was the best predictor of CSS while percent-positive biopsies, risk group,V100 and hypertension predicted for bPFS. Patient age and tobacco use were the strongest predictors of OS. One-hundred and twenty-eight patients have died with 108 (84.4%) of the deaths the result of cardiovascular/pulmonary disease (73) and second malignancies (35). To date, 12 patients have died of metastatic prostate cancer. Conclusions: Following brachytherapy, obesity did not impact CSS, bPFS or OS. Cardiovascular or pulmonary disease and second malignancies substantially outweighed prostate cancer as competing causes of death. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- R. Galbreath
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - G. S. Merrick
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - W. Butler
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - K. Wallner
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - Z. Allen
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - E. Adamovich
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| |
Collapse
|
24
|
Adamovich E, Merrick GS, Galbreath R, Butler W, Wallner K, Allen Z, Gutman S. The impact of primary Gleason pattern on survival following brachytherapy for Gleason score 7 prostate cancer. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.15588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
15588 Background: A recent radical prostatectomy series reported lower rates of biochemical control and cause-specific survival in Gleason score 7 patients with primary Gleason pattern 4. In this study, we evaluated the impact of Gleason 4+3 versus 3+4 on cause-specific, biochemical progression-free and overall survival in patients managed with permanent prostate brachytherapy. Methods: From April 1995 to June 2003, 530 prostate cancer patients underwent brachytherapy for clinical stage T1b-T3c (2002 AJCC) prostate cancer with Gleason score 3+4 (n=300) or Gleason score 4+3 (n=230) histology. All patients underwent brachytherapy more than three years prior to analysis. The mean and median follow-up was 6.0 and 5.7 years, respectively (range 3.2–11.2 years). Of the evaluated cohort, 412 (77.7%) received supplemental XRT and 177 (33.4%) received androgen deprivation therapy. No statistical differences were discerned between the use of XRT, however, Gleason 4+3 patients were more likely (37.4% versus 30.3%, p=0.002) to receive ADT. Multiple clinical, treatment and dosimetric parameters were evaluated as predictors of cause-specific, biochemical progression-free and overall survival. Results: At 10 years, primary Gleason 3+4 versus 4+3 did not predict for cause-specific survival (96.7% versus 93.3%, p=0.506), biochemical progression-free (97.0 versus 92.9%, p=0.085) or overall survival (77.0% versus 78.0%, p=0.9333). Cox linear regression analysis demonstrated no significant predictors for cause-specific survival while pre-treatment PSA, prostate volume and clinical stage predicted for biochemical progression-free survival. Patient age, tobacco use and diabetes were the strongest predictor for overall survival. To date, 57 patients have died (25 with Gleason 4+3 and 32 with Gleason 3+4). Of the deaths, 76% were due to cardiovascular events or second malignancies. To date, 4 patients (2 in each cohort) have died of metastatic prostate cancer. Conclusions: Following brachytherapy, the primary Gleason pattern did not impact cause-specific, biochemical progression-free or overall survival in Gleason score 7 prostate cancer. Cardiovascular disease and second malignancies were responsible for 9 times more deaths than prostate cancer. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- E. Adamovich
- Wheeling Hospital, Wheeling, WV; Ohio University Eastern, St. Clairsville, OH; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - G. S. Merrick
- Wheeling Hospital, Wheeling, WV; Ohio University Eastern, St. Clairsville, OH; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - R. Galbreath
- Wheeling Hospital, Wheeling, WV; Ohio University Eastern, St. Clairsville, OH; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - W. Butler
- Wheeling Hospital, Wheeling, WV; Ohio University Eastern, St. Clairsville, OH; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - K. Wallner
- Wheeling Hospital, Wheeling, WV; Ohio University Eastern, St. Clairsville, OH; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - Z. Allen
- Wheeling Hospital, Wheeling, WV; Ohio University Eastern, St. Clairsville, OH; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - S. Gutman
- Wheeling Hospital, Wheeling, WV; Ohio University Eastern, St. Clairsville, OH; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| |
Collapse
|
25
|
Allen Z, Merrick GS, Butler W, Wallner K, Galbreath R, Adamovich E, Lief J. Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer treated with brachytherapy and supplemental external beam. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.15578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
15578 Background: To determine cause-specific (CSS), biochemical progression-free (bPFS) and overall survival (OS) in high risk prostate cancer patients undergoing brachytherapy with or without supplemental therapies. Methods: From April 1995 through July 2002, 204 patients with high risk prostate cancer (Gleason score = 8 and/or PSA > 20 ng/mL and/or clinical stage = T2c) underwent brachytherapy with or without supplemental therapies. Of the 204 patients, 193 (94.6%) received supplemental XRT and 119 (58.3%) received ADT (ADT = 6 months n=40 and ADT > 6 months n = 79). Median follow-up was 7.0 years. All patients were implanted at least 4 years prior to analysis. BPFS was defined by a PSA = 0.40 ng/mL after nadir. Multiple clinical, treatment and dosimetric parameters were evaluated for the impact on survival. Results: The ten-year CSS, bPFS and OS were 88.9%, 86.6% and 68.6%, respectively. A statistically significant difference in bPFS was discerned between hormone naïve, ADT = 6 months and ADT > 6 month cohorts (79.7% vs. 95.0% vs. 89.9%, p= 0.032). ADT did not impact CSS (94.0% vs. 87.1%, p=0.983 ) or OS (65.2% vs. 70.3%, p = 0.713). For bPFS patients, the median post-treatment PSA was < 0.04 ng/mL. A Cox linear regression analysis demonstrated that Gleason score was the best predictor of CSS while percent positive biopsies and duration of ADT best predicted for bPFS. OS was best predicted by Gleason score and diabetes. Thirty-eight patients have died with 26 of the deaths due to cardiovascular/pulmonary disease or second malignancy. Eleven patients have died of metastatic prostate cancer. Conclusions: Androgen deprivation therapy improved 10-year bPFS without statistical impact on CSS or OS. Death as a result of cardiovascular/pulmonary disease and second malignancies were more than twice as common as prostate cancer deaths. Strategies to improve cardiovascular health should positively impact overall survival. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- Z. Allen
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH
| | - G. S. Merrick
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH
| | - W. Butler
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH
| | - K. Wallner
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH
| | - R. Galbreath
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH
| | - E. Adamovich
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH
| | - J. Lief
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH
| |
Collapse
|
26
|
Merrick GS, Gutman S, Adamovich E, Anderson R, Allen Z, Butler W, Wallner K. Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy: Implications for brachytherapy treatment planning. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.15533] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
15533 Background: Prostate cancer remains undetected in approximately one-third of patients following standard transrectal ultrasound-guided biopsy. In this study, we evaluated prostate cancer incidence, anatomic distribution, Gleason score profile and tumor burden in patients diagnosed by transperineal template-guided saturation biopsy (TTSB). Methods: One hundred and seventeen patients underwent TTSB. TTSB was performed under general anesthesia. All but one patient had undergone at least one prior negative TRUS biopsy. Criteria for inclusion included an elevated PSA and/or the diagnosis of ASAP or high-grade PIN on prior biopsy. The prostate gland was divided into 24 regional biopsy locations with 1–3 biopsies per region. The median number of biopsy cores was 50. Multiple clinical parameters were evaluated as predictors for prostate cancer diagnosis. Results: The mean patient age was 64.8 years with a mean PSA of 9.1 ng/mL and a prostate volume of 78.6 cm3. On average, patients had undergone 2.1 prior negative TRUS biopsies with a mean of 22.4 core biopsies. Prostate cancer was diagnosed in 49 patients (41.9%) with a Gleason score distribution of 6–9. Patients with a prostate volume of = 60 cm3 had a higher rate of cancer diagnosis compared to patients with larger glands (66% vs. 30%). Although no anatomic region of the prostate gland was spared of cancer, there was a preponderance of anterior-based malignancies. In patients with prostate cancer, an average of 9.9 cores were involved. In multivariate analysis, pre-saturation biopsy diagnosis and prostate volume were the best predictors for prostate cancer diagnosis. Conclusions: Transperineal template-guided saturation biopsy diagnosed prostate cancer in 41.9% of previously biopsied patients. Considerable anatomic variability in prostate cancer distribution was documented. Based on this and other reports, cancer eradication will be dependent on treatment of the entire prostate gland. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- G. S. Merrick
- Wheeling Hosp, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - S. Gutman
- Wheeling Hosp, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - E. Adamovich
- Wheeling Hosp, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - R. Anderson
- Wheeling Hosp, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - Z. Allen
- Wheeling Hosp, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - W. Butler
- Wheeling Hosp, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| | - K. Wallner
- Wheeling Hosp, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA
| |
Collapse
|
27
|
Bostancic C, Merrick GS, Butler W, Wallner K, Allen Z, Galbreath R, Lief J, Gutman S. Prediction of PSA spikes by isotope and patient age following permanent prostate brachytherapy. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.15535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
15535 Background: To evaluate prostate specific antigen (PSA) spikes (bounces) following permanent prostate brachytherapy in low-risk patients randomized to Pd-103 or I-125. Methods: The study population consisted of 164 prostate cancer patients who were part of a prospective randomized trial comparing Pd-103 with I-125 for low-risk disease. Sixty-one patients (37.2%) received short course cytoreductive androgen deprivation therapy (ADT). No patient received supplemental XRT. The median follow-up was 5.4 years. All patients were implanted at least 3 years prior to analysis. On average, 10.1 post-treatment PSA’s were obtained per patient. Biochemical disease-free survival was defined as a PSA = 0.40 ng/mL after nadir. A PSA spike was defined as a rise of = 0.2 ng/mL followed by a durable decline to pre- spike levels. Multiple clinical, treatment and dosimetric parameters were evaluated as predictors for a PSA spike. Results: Forty- four patients (26.9%) developed a PSA spike including 45.7% (21/46) of the hormone naïve I-125 patients and 14.0% (8/57) of the hormone naïve Pd-103 patients. In hormone naïve patients, the mean time between implant and spike was 22.6 months and 18.7 months for I-125 and Pd-103 patients, respectively. In patients receiving neoadjuvant ADT, the incidence of spikes was comparable between isotopes (28.1% for I- 125 and 20.7% for Pd-103). The incidence of spikes was substantially different in patients < 65 vs = 65 years of age (16.3% vs. 38.5%). In multivariate Cox regression analysis, patient age at implant (p < 0.001) and isotope (p = 0.002) were significant predictors for spike. Conclusions: In low-risk prostate cancer patients, PSA spikes are most common in patients implanted with I-125 and/or younger than 65 years of age. Differences in isotope-related spikes are most pronounced in hormone naïve patients. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- C. Bostancic
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH; Wheeling Jesuit University, Wheeling, WV
| | - G. S. Merrick
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH; Wheeling Jesuit University, Wheeling, WV
| | - W. Butler
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH; Wheeling Jesuit University, Wheeling, WV
| | - K. Wallner
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH; Wheeling Jesuit University, Wheeling, WV
| | - Z. Allen
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH; Wheeling Jesuit University, Wheeling, WV
| | - R. Galbreath
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH; Wheeling Jesuit University, Wheeling, WV
| | - J. Lief
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH; Wheeling Jesuit University, Wheeling, WV
| | - S. Gutman
- Wheeling Hospital, Wheeling, WV; Puget Sound Healthcare Cooperation, Group Health, Seattle, WA; Ohio University Eastern, St. Clairsville, OH; Wheeling Jesuit University, Wheeling, WV
| |
Collapse
|
28
|
Butler W, Cyr N, Kurko B, Anderson R. SU-FF-T-423: Transmission Properties of Aluminum and Brass Used for Solid IMRT Compensators in Megavoltage Photon Beams. Med Phys 2007. [DOI: 10.1118/1.2761148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
29
|
Butler W, Bouffard M, Hines A, Merrick G. SU-FF-T-386: Statistical Distribution of Strengths for Various Models of Low Energy Permanent Brachytherapy Sources. Med Phys 2007. [DOI: 10.1118/1.2761111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
30
|
|
31
|
Galbreath R, Merrick G, Butler W, Wallner K, Allen Z, Adamovich E. 2287. Int J Radiat Oncol Biol Phys 2006. [DOI: 10.1016/j.ijrobp.2006.07.694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
32
|
Adamovich E, Merrick G, Gutman S, Butler W, Wallner K, Allen Z, Galbreath R, Lief J, Anderson R. 2264. Int J Radiat Oncol Biol Phys 2006. [DOI: 10.1016/j.ijrobp.2006.07.671] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
33
|
Lief J, Merrick G, Butler W, Wallner K, Galbreath R, Allen Z. 2228. Int J Radiat Oncol Biol Phys 2006. [DOI: 10.1016/j.ijrobp.2006.07.634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
34
|
Kurko B, Merrick G, Gutman S, Butler W, Wallner K, Allen Z, Galbreath R, Lief J. 2311. Int J Radiat Oncol Biol Phys 2006. [DOI: 10.1016/j.ijrobp.2006.07.719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
35
|
Grimm P, Merrick G, Butler W, Blasko J, Sylvester J, Allen Z, Chaudry U, Mazza A. 2871. Int J Radiat Oncol Biol Phys 2006. [DOI: 10.1016/j.ijrobp.2006.07.1290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
36
|
Allen Z, Grimm P, Merrick G, Butler W, Chaudhry U, Mazza A. WE-C-224C-02: Preliminary Analysis of ProQura, a Multi-Institutional Database of Prostate Brachytherapy Dosimetry. Med Phys 2006. [DOI: 10.1118/1.2241707] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
37
|
Butler W, Merrick G, Wallner K, Allen Z, Kurko B, Anderson R, Galbreath R. SU-FF-T-239: Extracapsular Radiation Dose Annulus Correlates with Biochemical Control in Low-Risk Brachytherapy Patients: Results of a Prospective Randomized Trial. Med Phys 2006. [DOI: 10.1118/1.2241161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
38
|
Wallner K, Merrick G, True L, Sherertz T, Sutlief S, Cavanagh W, Butler W. 20 Gy Versus 44 Gy Supplemental Beam Radiation With Pd-103 Prostate Brachytherapy: Preliminary Biochemical Outcomes From a Prospective Randomized Multi-Center Trial. J Urol 2006. [DOI: 10.1016/s0022-5347(05)00588-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- K. Wallner
- Department of Veterans Affairs, Radiation Oncology, Puget Sound Health Care System, Departments of Radiation Oncology and Pathology, University of Washington and Department of Radiation Oncology, Group Health Cooperative, Seattle, Washington, and Schiffler Cancer Center, Wheeling, West Virginia
| | - G. Merrick
- Department of Veterans Affairs, Radiation Oncology, Puget Sound Health Care System, Departments of Radiation Oncology and Pathology, University of Washington and Department of Radiation Oncology, Group Health Cooperative, Seattle, Washington, and Schiffler Cancer Center, Wheeling, West Virginia
| | - L. True
- Department of Veterans Affairs, Radiation Oncology, Puget Sound Health Care System, Departments of Radiation Oncology and Pathology, University of Washington and Department of Radiation Oncology, Group Health Cooperative, Seattle, Washington, and Schiffler Cancer Center, Wheeling, West Virginia
| | - T. Sherertz
- Department of Veterans Affairs, Radiation Oncology, Puget Sound Health Care System, Departments of Radiation Oncology and Pathology, University of Washington and Department of Radiation Oncology, Group Health Cooperative, Seattle, Washington, and Schiffler Cancer Center, Wheeling, West Virginia
| | - S. Sutlief
- Department of Veterans Affairs, Radiation Oncology, Puget Sound Health Care System, Departments of Radiation Oncology and Pathology, University of Washington and Department of Radiation Oncology, Group Health Cooperative, Seattle, Washington, and Schiffler Cancer Center, Wheeling, West Virginia
| | - W. Cavanagh
- Department of Veterans Affairs, Radiation Oncology, Puget Sound Health Care System, Departments of Radiation Oncology and Pathology, University of Washington and Department of Radiation Oncology, Group Health Cooperative, Seattle, Washington, and Schiffler Cancer Center, Wheeling, West Virginia
| | - W. Butler
- Department of Veterans Affairs, Radiation Oncology, Puget Sound Health Care System, Departments of Radiation Oncology and Pathology, University of Washington and Department of Radiation Oncology, Group Health Cooperative, Seattle, Washington, and Schiffler Cancer Center, Wheeling, West Virginia
| |
Collapse
|
39
|
Galbreath R, Merrick G, Butler W, Wallner K, Allen Z, Adamovich E. Prognostic Significance of Perineural Invasion on Biochemical Progression-Free Survival Following Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 2005. [DOI: 10.1016/j.ijrobp.2005.07.563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
40
|
Gutman S, Merrick G, Butler W, Wallner K, Allen Z, Galbreath R. Influence of Preimplant International Prostate Symptom Score on Urinary Morbidity Following Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 2005. [DOI: 10.1016/j.ijrobp.2005.07.553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
41
|
Herstein A, Wallner K, Merrick G, Mitsuyama P, Armstrong J, True L, Cavanagh W, Butler W. I-125 Versus Pd-103 for Low Risk Prostate Cancer: Morbidity Outcomes From a Prospective Randomized Multi-center Controlled Trial. Int J Radiat Oncol Biol Phys 2005. [DOI: 10.1016/j.ijrobp.2005.07.543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
42
|
Galbreath R, Merrick G, Butler W, Anderson R, Allen Z. SU-FF-T-49: Prostate Brachytherapy-Induced Urethral Strictures. Med Phys 2005. [DOI: 10.1118/1.1997720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
43
|
Galbreath R, Beekman M, Merrick G, Butler W, Allen Z, Gutman S, Usher J. SU-FF-T-52: Selecting Patients with a Pretreatment Post-Void Residual Urine < 100 Cc May Favorably Influence Brachytherapy-Related Urinary Morbidity. Med Phys 2005. [DOI: 10.1118/1.1997723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
44
|
Adamovich E, Merrick G, Butler W, Galbreath R, Allen Z. SU-FF-T-48: Prognostic Significance of Perineural Invasion On Biochemical Progression-Free Survival Following Prostate Brachytherapy. Med Phys 2005. [DOI: 10.1118/1.1997719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
45
|
Allen Z, Merrick G, Butler W, Wallner K, Kurko B, Anderson R, Murray B, Galbreath R. Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.4712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Z. Allen
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA
| | - G. Merrick
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA
| | - W. Butler
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA
| | - K. Wallner
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA
| | - B. Kurko
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA
| | - R. Anderson
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA
| | - B. Murray
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA
| | - R. Galbreath
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA
| |
Collapse
|
46
|
Merrick G, Butler W, Galbreath R, Allen Z, Adamovich E. SU-FF-T-53: The Impact of Primary Gleason Grade On Biochemical Outcome Following Brachytherapy for Hormone Naïve Gleason Score 7 Prostate Cancer. Med Phys 2005. [DOI: 10.1118/1.1997724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
47
|
Allen Z, Merrick G, Butler W, Kurko B, Anderson R, Murray B, Galbreath R. SU-FF-T-27: Detailed Urethral Dosimetry in the Evaluation of Prostate Brachytherapy-Related Urinary Morbidity. Med Phys 2005. [DOI: 10.1118/1.1997698] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
48
|
Napolitano M, Butler W. SU-FF-T-40: Monte Carlo Calculation of Pd-103 Prostate Implant Treatment Plan. Med Phys 2005. [DOI: 10.1118/1.1997711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
49
|
Butler W, Niehaus A, Merrick G, Allen Z, Galbreath R, Adamovich E. SU-FF-T-51: Relationship Between Isotope, Prostate Volume and Urinary Morbidity Following Prostate Brachytherapy. Med Phys 2005. [DOI: 10.1118/1.1997722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
50
|
Butler W, Merrick G, Wallner K, Galbreath R, Allen Z, Adamovich E. The impact of primary Gleason grade on biochemical outcome following brachytherapy for Gleason score 7 prostate cancer. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.4699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- W. Butler
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA; Wheeling Hosp, Wheeling, WV
| | - G. Merrick
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA; Wheeling Hosp, Wheeling, WV
| | - K. Wallner
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA; Wheeling Hosp, Wheeling, WV
| | - R. Galbreath
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA; Wheeling Hosp, Wheeling, WV
| | - Z. Allen
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA; Wheeling Hosp, Wheeling, WV
| | - E. Adamovich
- Schiffler Cancer Ctr, Wheeling, WV; Univ of Washington, Seattle, WA; Wheeling Hosp, Wheeling, WV
| |
Collapse
|